Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant

Cell Mol Immunol. 2022 Mar;19(3):445-446. doi: 10.1038/s41423-022-00837-6. Epub 2022 Jan 24.

Wei Zhang^#^{1

2}, Linfen Huang^#^{1

2}, Gang Ye^{1

2}, Qibin Geng^{1

2}, Nwando Ikeogu³, Morgan Harris³, Gayathri Dileepan³, Kristina Burrack^{3

4}, Lanying Du⁵, Anne Frosch^{6

7}, Fang Li^{8

9}

¹ Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN, USA.
² Center for Coronavirus Research, University of Minnesota, Saint Paul, MN, USA.
³ Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
⁴ Hennepin Healthcare Department of Medicine, Hennepin Healthcare Research Institute, Minneapolis, MN, USA.
⁵ Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
⁶ Department of Medicine, University of Minnesota, Minneapolis, MN, USA. anne.frosch@hcmed.org.
⁷ Hennepin Healthcare Department of Medicine, Hennepin Healthcare Research Institute, Minneapolis, MN, USA. anne.frosch@hcmed.org.
⁸ Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN, USA. lifang@umn.edu.
⁹ Center for Coronavirus Research, University of Minnesota, Saint Paul, MN, USA. lifang@umn.edu.

^# Contributed equally.

No abstract available

Publication types